Less than 1 year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Business Acquisition [Axis] Business Acquisition [Axis] Agreement termination notice period Variable Interest Entity, Agreement Termination Notice, Period Variable Interest Entity, Agreement Termination Notice, Period Restatement [Axis] Revision of Prior Period [Axis] Increase (Decrease) in Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High Unrealized loss on marketable securities, net of tax Unrealized loss on marketable securities, net of tax Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Additional cash payments upon milestone achievements maximum Business Combination, Contingent Consideration Arrangements, Consecutive Twelve-Month Net Sales Threshold, Period Two Business Combination, Contingent Consideration Arrangements, Consecutive Twelve-Month Net Sales Threshold, Period Two Consecutive trading day period (in days) Debt Instrument, Convertible, Threshold Consecutive Trading Days Property and equipment, gross Property, Plant and Equipment, Gross APOKYN and SPN-830 APOKYN And SPN-830 [Member] APOKYN And SPN-830 Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Prepaid expenses and other current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets Other Income and Expenses [Abstract] Other Income and Expenses [Abstract] Additional paid-in capital Additional Paid in Capital Financial Instruments [Domain] Financial Instruments [Domain] Statistical Measurement [Domain] Statistical Measurement [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Schedule of Finite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Interest rate Debt Instrument, Interest Rate, Stated Percentage Sales and maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Other noncash adjustments, net Other Noncash Income (Expense) Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization 3 years to 4 years Available For Sale Securities Debt Maturities Three Years Through Four Years Fair Value Fair value of available-for-sale debt securities maturing in the third fiscal year through the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Net earnings Net earnings Net Income (Loss) Attributable to Parent Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Conversion Circumstance Two Conversion Circumstance Two [Member] Conversion Circumstance Two Income per share Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock equivalents excluded in the calculation of diluted income per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Equity Component [Domain] Equity Component [Domain] SPN-830 First Commercial And Sale SPN-830 First Commercial And Sale [Member] SPN-830 First Commercial And Sale Total fair value of assets acquired Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets Acquired Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets Acquired Total assets at fair value Total assets at fair value Assets, Fair Value Disclosure Leases Lessee, Operating Leases [Text Block] Investment, Name [Domain] Investment, Name [Domain] Leases Lessee, Lease, Description [Line Items] NAMENDA XR/Namzaric Qui Tam Litigation NAMENDA XR/Namzaric Qui Tam Litigation [Member] NAMENDA XR/Namzaric Qui Tam Litigation Conversion option stock price trigger (in dollars per share) Debt Instrument, Convertible, Stock Price Trigger Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Supplemental cash flow information Supplemental Cash Flow Information [Abstract] Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of operating segments Number of Operating Segments Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Convertible notes (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Outstanding at the end of the period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Axis] Award Type [Axis] Denominator: Weighted Average Number of Shares Outstanding, Basic [Abstract] Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Operating lease liabilities, current portion Operating Lease, Liability, Current Accrued product returns Accrued Product Returns Represents the amount of accrued product returns. Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Summary of restricted stock units Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Acquired in-process research and development In Process Research and Development [Member] Milestone payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Costs and expenses Costs and Expenses [Abstract] Long-term marketable securities Debt Securities, Noncurrent [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Legal Entity [Axis] Legal Entity [Axis] Convertible notes, net Long-Term Debt, Excluding Current Maturities Variable Interest Entity, Not Primary Beneficiary Variable Interest Entity, Not Primary Beneficiary [Member] Total liabilities Liabilities Share-Based Payments Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Goodwill, adjustments Goodwill, Purchase Accounting Adjustments Finite-lived and indefinite-lived intangible assets acquired as part of business combination Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Amortization of premium/discount on marketable securities Investment Income, Net, Amortization of Discount and Premium Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Issuance of common stock in connection with the Company’s equity award plans Stock Issued During Period, Value, New Issues Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Corporate and municipal debt securities Debt Securities, Available-for-Sale, Current Document Type Document Type Weighted Average Exercise Price (per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Convertible Senior Notes Due 2023 Long-Term Debt [Text Block] Number of RSUs Number of PSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Adamas Pharmaceuticals Adamas Pharmaceuticals [Member] Adamas Pharmaceuticals Assets: Assets, Fair Value Disclosure [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Additional cash payments upon milestone achievements minimum Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, Low Nonvested, beginning balance (in dollars per share) Nonvested, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Purchase of property and equipment and deferred legal fees paid Payments To Acquire Property, Plant, And Equipment, And Deferred Legal Fees Payments To Acquire Property, Plant, And Equipment, And Deferred Legal Fees Raw materials Inventory, Work in Process and Raw Materials, Net of Reserves 1 year to 2 years Available For Sale Securities Debt Maturities After One Through Two Years Fair Value Fair value of available-for-sale debt securities maturing after the first year through the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Deferred income tax provision Deferred Income Tax Expense (Benefit) Accrued clinical trial costs Accrued Clinical Trial and Clinical Supply Costs Current Represents the amount of clinical trial and clinical supply costs accrued. Marketable securities - restricted (SERP) Assets for Plan Benefits, Defined Benefit Plan Lease liabilities, current Lease Liabilities, Current [Abstract] Lease Liabilities, Current Financial Instrument [Axis] Financial Instrument [Axis] Acquired developed technology and product rights Developed Technology Rights [Member] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] APOKYN APOKYN [Member] APOKYN Document Period End Date Document Period End Date Schedule of financial liabilities that are not carried at fair value Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block] Total identifiable net assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Accounting Standards Update 2020-06 Accounting Standards Update 2020-06 [Member] Total assets Assets Debt Disclosure [Abstract] Debt Disclosure [Abstract] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total PSUs Performance Shares [Member] Total Accrued Liabilities, Current Schedule of accounts payable and accrued liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Convertible notes, net Long-Term Debt, Current Maturities Numerator: Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Accounting Policies [Abstract] Interest expense Interest Expense, Debt Accrued compensation Employee-related Liabilities, Current Earnings before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Amortization of deferred financing costs and debt discount Amortization of Debt Issuance Costs and Discounts Earnings per Share Earnings Per Share [Text Block] Customer [Axis] Customer [Axis] Composition of Other Balance Sheet Items Supplemental Balance Sheet Disclosures [Text Block] Sales-based contingent consideration liabilities Sales-Based Contingent Consideration Liability [Member] Sales-Based Contingent Consideration Liability Award Type [Domain] Award Type [Domain] Accrued product rebates Accrued Rebates Represents the amount of accrued rebates. Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Computer equipment Computer Equipment [Member] SPN-830 NDA Approval Milestone SPN-830 NDA Approval Milestone [Member] SPN-830 NDA Approval Milestone Cash consideration paid Payments to Acquire Businesses, Gross Other Manufactured Product, Other [Member] Entity Registrant Name Entity Registrant Name Issuance of common stock in connection with the Company’s equity award plans (in shares) Stock Issued During Period, Shares, New Issues Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory USWM Enterprises MDD US Enterprises LLC (Formerly USWM Enterprises) [Member] MDD US Enterprises LLC (Formerly USWM Enterprises) Regulatory and developmental contingent consideration liabilities Regulatory And Developmental Contingent Consideration Liability [Member] Regulatory And Developmental Contingent Consideration Liability Entity Address, City or Town Entity Address, City or Town Leases [Abstract] Leases [Abstract] Consolidation Consolidation, Policy [Policy Text Block] Market-Based Units Market Based Units [Member] Market Based Units Minimum Minimum [Member] Conversion rate for the notes (in shares per $1,000 principal amount) Debt Instrument, Convertible, Conversion Ratio Money market securities and commercial paper Money Market Securities And Commercial Paper [Member] Money Market Securities And Commercial Paper Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Royalty revenues Royalty [Member] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Intangibles Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Fair Value of Financial Instruments and Contingent Consideration Fair Value Disclosures [Text Block] Investment, Name [Axis] Investment, Name [Axis] Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Accrued product returns and rebates Total Accrued Product Returns and Rebates. Carrying value as of the balance sheet date of accrued product returns and rebates. Trading Symbol Trading Symbol Entity File Number Entity File Number Lease liabilities, long-term Lease Liabilities, Noncurrent [Abstract] Lease Liabilities, Noncurrent 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Four Research and development Research and Development Expense Accrued product costs Accrued Product Costs, Current Accrued Product Costs, Current Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period RSUs Restricted Stock Units (RSUs) [Member] Effective tax rate Effective Income Tax Rate Reconciliation, Percent Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Use of Estimates Use of Estimates, Policy [Policy Text Block] Cash and Money market funds Cash and Cash Equivalents, Fair Value Disclosure USWM Acquisition Business Combination Disclosure [Text Block] Other income (expense) Other Nonoperating Income (Expense) [Abstract] Other comprehensive earnings Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Accrued product returns and rebates Increase (Decrease) In Accrued Product Returns And Rebates Amount of increase (decrease) in product returns and rebates. SPN-830 FDA Acceptance Milestone SPN-830 FDA Acceptance Milestone [Member] SPN-830 FDA Acceptance Milestone Total purchase price Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Balance at December 31, 2021 Balance at June 30, 2022 (unaudited) Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Concentration risk percentage (more than) Concentration Risk, Percentage Pro forma net loss Business Acquisition, Pro Forma Net Income (Loss) Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Accounts payable and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Income Tax (Benefit) Expense Income Tax Disclosure [Text Block] Deferred income tax liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Deferred Income Tax Liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Deferred Income Tax Liabilities Finished goods Inventory, Finished Goods, Net of Reserves Total intangible assets, carrying amount, gross Intangible Assets, Gross (Excluding Goodwill) Amortization of intangible assets Amortization of intangible assets Amortization of Intangible Assets Strike price of the warrant transactions (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Schedule of Goodwill Schedule of Goodwill [Table Text Block] Cash paid for interest on convertible notes Interest Paid, Excluding Capitalized Interest, Operating Activities Basic (in dollars per share) Earnings per share, basic (in dollars per share) Earnings Per Share, Basic Operating lease liabilities, long-term Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability, Noncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease, Liability, Noncurrent New Accounting Pronouncements or Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Accounts payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Concentration Risk Type [Domain] Concentration Risk Type [Domain] Other income from Navitor (see Note 5) Payments For (Proceeds From) Collaborative Arrangement, Investment Payments For (Proceeds From) Collaborative Arrangement, Investment Loss contingency, damages sought, value Loss Contingency, Damages Sought, Value Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Total stockholders’ equity Balance Balance Stockholders' equity attributable to parent Stockholders' Equity Attributable to Parent Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Entity Interactive Data Current Entity Interactive Data Current Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Three Reconciliation of the beginning and ending balances related to the contingent consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Nonrecourse liability related to sale of future royalties, long-term Non-Recourse Liability, Noncurrent Non-Recourse Liability, Noncurrent Money market securities and funds Money Market Funds [Member] Threshold for development costs payments Collaborative Arrangement, Threshold For Development Costs Payments Collaborative Arrangement, Threshold For Development Costs Payments Retained Earnings Retained Earnings [Member] Common Stock Common Stock [Member] Schedule of share-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Contingent consideration Contingent consideration Business Combination, Contingent Consideration, Liability Statement [Table] Statement [Table] 2 years to 3 years Available For Sale Securities Debt Maturities Two Years Through Three Years Fair Value Fair value of available-for-sale debt securities maturing in the second fiscal year through the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Optional lease renewal term (in years) Lessee, Operating Lease, Renewal Term Long-term marketable securities Marketable Securities, Noncurrent Document Quarterly Report Document Quarterly Report Current assets Assets, Current [Abstract] Operating lease liabilities, long-term Operating lease liabilities, long-term Operating Lease, Liability, Noncurrent Statistical Measurement [Axis] Statistical Measurement [Axis] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Payment of contingent consideration Payment of contingent consideration Payment for Contingent Consideration Liability, Financing Activities Capitalized patent defense costs Patent Defense Costs [Member] Represents information concerning the capitalized patent defense costs related to the Watson litigation. Acquired in-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Leasehold improvements Leasehold Improvements [Member] SPN-830 NDA Approval Milestone, Time-Based SPN-830 NDA Approval Milestone, Time-Based [Member] SPN-830 NDA Approval Milestone, Time-Based Retained earnings Retained Earnings (Accumulated Deficit) Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Purchases of marketable securities Payments to Acquire Marketable Securities Fair Value (Level 2) Convertible Debt, Fair Value Disclosures Equity Components [Axis] Equity Components [Axis] Cardinal Health Cardinal Health [Member] Cardinal Health Recurring Fair Value, Recurring [Member] Litigation Case [Domain] Litigation Case [Domain] Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Business acquisition, pro forma information Business Acquisition, Pro Forma Information [Table Text Block] Restatement [Domain] Revision of Prior Period [Domain] Document Fiscal Year Focus Document Fiscal Year Focus Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement Statement [Line Items] Contingent Consideration Disclosure Contingent Consideration Disclosure [Text Block] Contingent Consideration Disclosure Nonvested, beginning balance (in shares) Nonvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Indefinite-Lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Contingent consideration, current portion Business Combination, Contingent Consideration, Liability, Current Total other income (expense) Nonoperating Income (Expense) Carrying Amount, Gross Finite-Lived Intangible Assets, Gross Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative Selling, General and Administrative Expense SPN-830 NDA Approval Milestone, Approval-Based SPN-830 NDA Approval Milestone, Approval-Based [Member] SPN-830 NDA Approval Milestone, Approval-Based Amortized cost Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss, Current Contingent consideration expense (gain) Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Accrued royalties Accrued Royalties, Current Operating lease assets Operating Lease, Right-of-Use Asset Gross unrealized losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Net product sales Product [Member] Accumulated Other Comprehensive Earnings (Loss) AOCI Attributable to Parent [Member] Change in fair value of operating lease acquired Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets Additional cash payments upon milestone achievements minimum Business Combination, Contingent Consideration Arrangements, Consecutive Twelve-Month Net Sales Threshold, Period One Business Combination, Contingent Consideration Arrangements, Consecutive Twelve-Month Net Sales Threshold, Period One Schedule of balance sheet information related to leases Lessee, Operating and Finance Lease, Balance Sheet Disclosure [Table Text Block] Lessee, Operating and Finance Lease, Balance Sheet Disclosure Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Document Transition Report Document Transition Report Local Phone Number Local Phone Number Summary of stock options and SAR activities Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating earnings Operating Income (Loss) Inventories Increase (Decrease) in Inventories Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Common stock issued upon conversion of notes (in shares) Debt Conversion, Converted Instrument, Shares Issued Total identifiable net assets, adjustments Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets (Liabilities), Net Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets (Liabilities), Net Other liabilities Other Sundry Liabilities, Noncurrent Effect of dilutive securities: Weighted Average Number of Shares Outstanding, Diluted, Adjustment [Abstract] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Common stock shares outstanding (in shares) Common Stock, Shares, Outstanding Goodwill Goodwill Balance as of December 31, 2021 Balance as of June 30, 2022 (unaudited) Goodwill Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Total liabilities at fair value Liabilities, Fair Value Disclosure MDD Subsidiaries MDD Subsidiaries [Member] MDD Subsidiaries Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Trokendi XR Trokendi Xr [Member] Represents information pertaining to Trokendi XR patent litigation. Income tax (benefit) expense Income Tax Expense (Benefit) Deferred income tax liabilities Deferred Income Tax Liabilities, Net Income Statement [Abstract] Income Statement [Abstract] Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Additional  Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Balance, January 1, 2022 Cumulative Effect, Period of Adoption, Adjusted Balance [Member] Cost of goods sold Cost of Goods and Services Sold Debt securities, available-for-sale, excluding accrued interest, allowance for credit loss, not previously recorded Debt Securities, Available-for-Sale, Excluding Accrued Interest, Allowance for Credit Loss, Not Previously Recorded Diluted (in shares) Weighted average shares outstanding, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of inventories Schedule of Inventory, Current [Table Text Block] Current debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt Schedule of unrestricted available-for-sale marketable securities Schedule of Available-for-Sale Securities Reconciliation [Table Text Block] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Weighted Average Remaining Contractual Term (in years) Share Based Compensation Arrangement by Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Common Stock, Value, Issued Common Stock, Value, Issued Conversion of debt to equity Debt Conversion, Original Debt, Amount Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Granted (in dollars per share) Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of common stock equivalents excluded in the calculation of diluted earnings per share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Conversion price, per share of common stock (in dollars per share) Debt Instrument, Convertible, Conversion Price Convertible Debt Convertible Debt [Member] Product Concentration Risk Product Concentration Risk [Member] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Cash and cash equivalents at beginning of year Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Three Major Customers Three Major Customers [Member] Three Major Customers Current liabilities Liabilities, Current [Abstract] Numerator for dilutive earnings per share Net Income (Loss) Available to Common Stockholders, Basic Common stock shares issued (in shares) Common Stock, Shares, Issued Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Cash distributions received Proceeds from Divestiture of Businesses and Interests in Affiliates Property and equipment additions from utilization of tenant improvement allowance Capital Expenditures Incurred but Not yet Paid Income Statement Location [Domain] Income Statement Location [Domain] Interest expense on nonrecourse liability related to sale of future royalties Interest Expense, Other Carrying Value Convertible Notes Payable, Noncurrent Fair value of financial instruments Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Finite-lived intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Principal amount of debt 2023 Notes Debt Instrument, Face Amount Remaining Weighted Average Life (Years) Finite-Lived Intangible Assets, Remaining Amortization Period After-tax interest expense for 2023 Notes Interest on Convertible Debt, Net of Tax Lab equipment and furniture Lab Equipment And Furniture [Member] Represents information pertaining to lab equipment and furniture. Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Attributable to Parent Litigation Case [Axis] Litigation Case [Axis] Lease assets obtained for new operating leases Right-of-Use Asset Obtained In Exchange For Operating And Finance Lease Liability Right-of-Use Asset Obtained In Exchange For Operating And Finance Lease Liability Pro forma total revenues Business Acquisition, Pro Forma Revenue Total fair value of liabilities assumed Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Construction-in-progress Construction in Progress [Member] Gross unrealized gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Entity Current Reporting Status Entity Current Reporting Status Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Other current liabilities Other Liabilities, Current Fair value of excess of the acquisition Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Excess Acquisition Date Fair Value Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Excess Acquisition Date Fair Value Other assets Other Assets, Noncurrent Earnings per share EPS Basic And Diluted [Abstract] EPS Basic And Diluted Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Depreciation and amortization Depreciation, Depletion and Amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Total fair value Total Debt Securities, Available-for-Sale, Excluding Accrued Interest McKesson McKesson [Member] McKesson Schedule of recognized identified assets acquired and liabilities assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of interest expense Interest Income and Interest Expense Disclosure [Table Text Block] Outstanding at the beginning of the period (in shares) Outstanding at the end of the period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Unamortized debt discount and deferred financing costs Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Number of shares per warrant entitled to holder (in shares) Class of Warrant or Right, Number of Shares in Which Holder Can be Entitled per Warrants at Strike Price Represents the information pertaining to the shares per warrant entitled to holders at strike price. Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Allowance for expected sales discounts and allowances Allowance for Expected Sales deductions Represents the allowance for sales discounts related to prompt-pay discounts and contractual fee for service arrangements to wholesalers and distributors. Contingent consideration Increase (Decrease) In Contingent Consideration Increase (Decrease) In Contingent Consideration Property and equipment, net Property, Plant and Equipment, Net Liabilities Liabilities [Abstract] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Contingents vale rights Business Combination, Contingent Consideration, Number Of Contingent Value Rights Per Common Share Business Combination, Contingent Consideration, Number Of Contingent Value Rights Per Common Share Cash and cash equivalents Cash and Cash Equivalents [Abstract] Cash paid for operating leases Operating Lease, Payments Change in fair value recognized in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Additional cash payments upon milestone achievements maximum Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Measurement Period Adjustments Prior Period Adjustment [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Long-term debt Total carrying value Long-Term Debt Interest and other income, net Other Nonoperating Income (Expense) Common stock shares authorized (in shares) Common Stock, Shares Authorized Contingent consideration, long-term Business Combination, Contingent Consideration, Liability, Noncurrent Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Maximum Maximum [Member] Accumulated other comprehensive earnings (loss), net of tax Accumulated Other Comprehensive Income (Loss), Net of Tax Schedule of accrued product returns and rebates Schedule of Accrued Product Returns and Rebates [Table Text Block] Tabular disclosure of the accrued product returns and rebates. Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Stock options, RSUs, PSUs Share-Based Payment Arrangement [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Schedule of fair value of the financial assets and liabilities Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block] Total current assets Assets, Current Cash paid for income taxes Income Taxes Paid, Net Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Business Acquisition [Line Items] Business Acquisition [Line Items] Entity Small Business Entity Small Business Balance (in shares) Balance (in shares) Shares, Outstanding Measurement Frequency [Domain] Measurement Frequency [Domain] Revenues Revenues [Abstract] Carrying Amount, Net Finite-Lived Intangible Assets, Net Accrued expenses and other current liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses And Other Current Liabilities Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Accrued Expenses And Other Current Liabilities Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Threshold trading days (whether or not consecutive) Debt Instrument, Convertible, Threshold Trading Days Software Computer Software, Intangible Asset [Member] Disaggregation of Revenue [Abstract] Disaggregation of Revenue [Abstract] Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Summary of performance stock unit Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Other liabilities Other Noncurrent Liabilities [Table Text Block] Convertible note hedge options issued (in shares) Debt Conversion, Converted Instrument, Warrants or Options Issued Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Consolidated Entities [Axis] Consolidated Entities [Axis] Total costs and expenses Costs and Expenses Realized gains from sales of marketable securities Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Conversion Circumstance One Conversion Circumstance One [Member] Conversion Circumstance One Marketable securities Debt Securities, Current [Abstract] Selling, general and administrative Selling, General and Administrative Expenses [Member] Schedule of intangible assets and goodwill Schedule of Intangible Assets and Goodwill [Table Text Block] Investments, Debt and Equity Securities [Abstract] As Initially Reported Previously Reported [Member] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Two Deferred tax liabilities, net Deferred Tax Liabilities, Net Number of established marketed products Number Of Established Marketed Products Number Of Established Marketed Products Liabilities and stockholders’ equity Liabilities and Equity [Abstract] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Payment to resolve U.S. Department of Justice allegations Litigation Settlement, Amount Awarded to Other Party Weighted average shares outstanding Weighted Average Number of Shares Outstanding, Diluted [Abstract] Inventories, net Total inventories Inventory, Net Annual minimum purchase quantity requirement amount Purchase Commitment, Annual Minimum Amount Committed Purchase Commitment, Annual Minimum Amount Committed Accounts payable Accounts Payable, Current Conversion rate of the notes on trading day (as percent) Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger Investments Equity Securities, FV-NI, Cost Schedule of contractual maturities of the unrestricted available-for-sale marketable securities held Investments Classified by Contractual Maturity Date [Table Text Block] Business Organization Nature of Operations [Text Block] Entity Filer Category Entity Filer Category Proceeds from issuance of common stock Proceeds from Issuance of Common Stock Basic (in shares) Weighted average shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Liabilities: Liabilities, Fair Value Disclosure [Abstract] Total Share-Based Payment Arrangement, Expense Noncash investing and financing activities Noncash Investing and Financing Items [Abstract] Security Exchange Name Security Exchange Name Outstanding at the beginning of the period (in dollars per share) Outstanding at the end of the period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Property and equipment Property, Plant and Equipment [Line Items] AmerisourceBergen Drug Corporation AmerisourceBergen Drug Corporation [Member] AmerisourceBergen Drug Corporation Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Stock option and Stock Appreciation Rights Stock Option Stock Appreciation Rights [Member] Represents information related to stock option awards for employees and non-employees as well as stock appreciation rights. Cover page. Cover [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] Depreciation and amortization expense Depreciation, Depletion and Amortization, Nonproduction Corporate and municipal debt securities Debt Securities, Available-for-Sale, Noncurrent Share-Based Payments Share-Based Payment Arrangement [Text Block] Work in process Inventory, Work in Process, Net of Reserves Disaggregated Revenues Revenue from Contract with Customer [Text Block] Total liabilities and stockholders’ equity Liabilities and Equity Goodwill [Roll Forward] Goodwill [Roll Forward] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Developed Technology Rights and Patent Defense Costs Developed Technology Rights And Patent Defense Costs [Member] Developed Technology Rights And Patent Defense Costs Stock options, RSU and SAR (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Organization, Consolidation and Presentation of Financial Statements [Abstract] Acquisition of USWM, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Share-based payments Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Marketable securities Marketable Securities, Current Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Diluted (in dollars per share) Earnings per share, diluted (in dollars per share) Earnings Per Share, Diluted Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Interest Expense Other Nonoperating Income and Expense [Text Block] Total lease liabilities Lease, Liability Lease, Liability Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Greater than 4 years Available For Sale Securities Debt Maturities, Thereafter, Fair Value Available For Sale Securities Debt Maturities, Thereafter, Fair Value Performance-Based Units Performance Based Units [Member] Performance Based Units Commitment period Long-Term Purchase Commitment, Period Customer Concentration Risk Customer Concentration Risk [Member] Deferred income tax liabilities adjustments Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed Corporate Debt Securities Corporate Debt Securities [Member] Cumulative effect of adoption of ASU 2020-06 Cumulative Effect, Period of Adoption, Adjustment [Member] Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] Entity Address, Address Line One Entity Address, Address Line One Long-term Purchase Commitment [Table] Long-Term Purchase Commitment [Table] Other assets Other Assets, Noncurrent [Abstract] Adamas Acquisition Adamas [Member] Adamas Product and Service [Axis] Product and Service [Axis] Nonrecourse liability related to sale of future royalties, long term Non Recourse Debt Sale of Future Royalties Noncurrent Noncurrent portion of debt, net of the amount due within one year or the normal operating cycle, if longer, related to the sale of future royalties, for which the creditor does not have general recourse to the debtor but rather has recourse only to the property used for collateral in the transaction or other specific property. Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Interest expense Total Interest Expense Oxtellar XR Oxtellar X R [Member] Represents information pertaining to Oxtellar XR product. Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Long-term Purchase Commitment [Line Items] Long-Term Purchase Commitment [Line Items] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Debt Conversion Description [Axis] Debt Conversion Description [Axis] Navitor Pharmaceuticals, Inc. Navitor Pharmaceuticals, Inc. [Member] Navitor Pharmaceuticals, Inc. Entity Tax Identification Number Entity Tax Identification Number GOCOVRI GOCOVRI [Member] GOCOVRI SPN-830 Future Sales Performance SPN-830 Future Sales Performance [Member] SPN-830 Future Sales Performance Advertising costs Advertising Expense Debt Conversion, Name [Domain] Debt Conversion, Name [Domain] Summary of disaggregation of revenues by nature Disaggregation of Revenue [Table Text Block] Qelbree Qelbree [Member] Qelbree Cash Cash [Member] Consolidated Entities [Domain] Consolidated Entities [Domain] VIE, qualitative or quantitative information, ownership percentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage Schedule of reconciliation of income tax expense at the U.S Federal statutory income tax rate to the entity's effective income tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Net change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Five Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Weighted Average Grant Date Fair Value per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Total purchase price Business Combination, Consideration Transferred Other accrued expenses Other Accrued Liabilities, Current Entity [Domain] Entity [Domain] Type of Adoption [Domain] Accounting Standards Update [Domain] City Area Code City Area Code Accrued professional fees Accrued Professional Fees, Current Assets Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Advertising Expense Advertising Cost [Policy Text Block] Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Navitor investment R&D expense (see Note 5) Research and Development in Process Share-based compensation expense Share-Based Payment Arrangement, Noncash Expense Warrants issued (in shares) Class of Warrant or Right, Outstanding Other liabilities Total Other Liabilities, Noncurrent Research and development Research and Development Expense [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] 2023 Finite-Lived Intangible Asset, Expected Amortization, Year One SPN-830 Regulatory and Commercial Activities SPN-830 Regulatory And Commercial Activities [Member] SPN-830 Regulatory And Commercial Activities Schedule of computation of basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Rights per share (in dollars per share) Business Combination, Contingent Consideration, Rights Per Share Business Combination, Contingent Consideration, Rights Per Share Summary of liability component of 2023 Notes Convertible Debt [Table Text Block] Non-cash royalty revenue Revenue From Royalty Agreement Represents revenue from the sale of certain royalty and milestone rights. Customer [Domain] Customer [Domain] Accounting Standards Update [Extensible Enumeration] Accounting Standards Update [Extensible Enumeration]